Glutathione: What Trials Show About Absorption and Skin Lightening
Educational overview — not medical advice. Glutathione has no established RDA or upper limit. This page never endorses IV glutathione. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Two separate honest questions, and they get two different answers. Absorption: the old "oral glutathione is destroyed in the gut" claim is overstated — Richie 2015's 6-month RCT (n=54) found 250mg and 1000mg/day raised body glutathione stores dose-dependently, real and solid. Skin lightening: small, short oral RCTs (Arjinpathana 2012, Weschawalit 2017) show a genuine but thin signal, positive yet limited to 4-12 weeks. IV glutathione is a different story entirely: no RCT efficacy evidence, not FDA-approved for skin lightening, and the Philippine FDA issued a public safety warning after adverse effects (Sonthalia 2016). This page never treats oral evidence as support for IV use.
As an Amazon Associate we earn from qualifying purchases. On best glutathione, 5 of 6 products disclose actual reduced-glutathione mg — ranked by that, then cost per actual mg, never commissions.
Start here
What glutathione is, and three claims that get conflated
Glutathione is a small molecule made from three amino acids (cysteine, glutamate, glycine) that your body produces on its own and uses as its master intracellular antioxidant — a real, textbook biochemical role, not a marketing invention. It's not an essential nutrient in the vitamin sense: there's no deficiency state, no RDA, and no government-set upper limit, so any claimed benefit of supplementing above what your body already makes has to stand on its own evidence. Glutathione marketing routinely blends three genuinely different claims into one confident pitch, and separating them is the entire point of this cluster. First, does oral glutathione raise your body's glutathione stores? Yes, and this is the best-supported claim here — Richie 2015 measured blood, erythrocyte, plasma, lymphocyte, and buccal-cell glutathione directly, over 6 months, in a dose-dependent RCT. Second, is oral glutathione a proven skin-lightening treatment? Positive, but thin — two small RCTs (Arjinpathana, Weschawalit) and one uncontrolled, single-arm open-label trial (Handog), all 4-12 weeks, none establishing long-term safety or a large effect. Third, is a specific delivery form (liposomal, S-acetyl, sublingual) more bioavailable than standard capsules? Largely unverified in humans — the one human head-to-head (Schmitt 2015) actually found sublingual beat standard oral, liposomal's edge is a rat-only finding, and S-acetyl has no published human absorption data at all. A strong finding on one of these three claims does not lend credibility to the other two, and this cluster never lets that happen.
Does it work? (the honest short version)
For raising your own glutathione levels: yes, reliably, at 250-1000mg/day over months, per Richie 2015 — this is real pharmacology with a clean dose-response curve. For skin lightening: modestly and short-term, in small trials that their own authors describe carefully. Arjinpathana's own conclusion, quoted directly, is that oral glutathione "results in a lightening of skin color in a small number of subjects" — not a dramatic or guaranteed effect, and long-term safety was explicitly not established. Handog's positive open-label result carries real limitations: no control group, no disclosed dose, and effects that can't be separated from expectation or measurement bias without a comparison arm. For "which form absorbs best": the honest answer is that nobody has run the human trial that would settle it. Schmitt 2015's finding that sublingual outperformed standard oral capsules is the only human head-to-head evidence in this pack, and it argues against, not for, the plain-capsule route being optimal — while liposomal and S-acetyl marketing claims currently rest on animal data or mechanism alone.
The one-line takeaway Oral glutathione's absorption problem is smaller than its reputation suggests (Richie 2015, real and dose-dependent). Its skin-lightening evidence is real but small and short (Arjinpathana, Weschawalit; Handog uncontrolled). IV glutathione for skin lightening has neither an efficacy record nor a clean safety record — oral evidence never justifies it. See the full absorption-and-skin breakdown.
The buying and safety problem
Five of the six products tracked here disclose an actual reduced-glutathione mg per serving directly on the label — a real, computable cost-per-mg comparison, unlike categories where the label hides the active dose behind an extract weight. The exception, and the one worth naming plainly, is Life Extension's Glutathione, Cysteine & C, which delivers only 50mg of actual glutathione per capsule — well under every trial dose in this pack — despite "Glutathione" leading the product name. NOW's combo product matches Arjinpathana's 500mg dose but adds milk thistle and alpha lipoic acid, making it a liver-support formula rather than a plain-glutathione cost comparator. See the full ranking, including why liposomal and S-acetyl products aren't ranked on absorption superiority, on best glutathione. On safety: no serious adverse events were reported across the oral human RCTs in this pack (Richie, Weschawalit, Arjinpathana, Handog), and S-acetyl-glutathione has a reassuring animal toxicology package (NOAEL 1500mg/kg/day, Camillerapp 2025) — though that's animal, not human, data. IV glutathione is a separate, flagged risk: no RCT in this pack tested it, it is not FDA-approved for skin lightening, and the Philippine FDA issued a public warning after adverse effects from off-label IV use for skin lightening (Sonthalia 2016). There is no pregnancy or breastfeeding safety data for glutathione at any dose or route. If your real goal is raising glutathione as cheaply and reliably as possible, also read NAC for liver & glutathione — NAC has stronger drug-grade evidence (it's the FDA-approved acetaminophen-overdose antidote) and is typically cheaper per effective dose.
On this page
Glutathione Benefits: What the Evidence Actually Supports
Looking for a specific product? See best glutathione ranked by cost per actual mg, not by absorption marketing →
Bioavailability first: the honest finding this whole page rests on
Glutathione's biggest marketing problem is also its biggest opportunity for honesty: it's a large molecule, and swallowing it doesn't obviously guarantee it reaches your cells intact. The claim that oral glutathione is "destroyed in the gut" is overstated at the level of raising your body's own stores — Richie 2015, PMID: 24791752, a 6-month randomized controlled trial in 54 healthy adults, found that 250mg and 1000mg/day oral reduced glutathione raised glutathione in blood, erythrocytes, plasma, lymphocytes, and buccal mucosal cells, dose- and time-dependently, with levels returning to baseline after a washout period — direct evidence the rise was caused by supplementation, not measurement drift. That's real pharmacology.
But "oral glutathione works" and "oral is the best way to raise it" are different claims, and only the first is well-supported. A head-to-head crossover trial (Schmitt 2015, PMID: 26262996) found a novel sublingual glutathione formulation raised plasma glutathione significantly more than standard oral capsules, and performed comparably to NAC. This is the foundation every benefit claim below has to be checked against: a claim that assumes glutathione "can't be absorbed at all" is wrong, but a claim that assumes any oral capsule is the optimal delivery route is unproven. See the full absorption breakdown for the complete trial-by-trial evidence.
Skin lightening: the biggest reason people search for this, and the thinnest evidence
Skin lightening drives most of the consumer demand for glutathione, and it's worth being blunt about the evidence behind it. Two placebo-controlled RCTs support a real but modest effect: Arjinpathana 2012, PMID: 20524875 (n=60, 500mg/day oral, 4 weeks) found melanin index dropped significantly at 2 of several measured sites, with the study authors' own conclusion stating only that it "results in a lightening of skin color in a small number of subjects" and explicitly flagging that long-term safety was not established. Weschawalit 2017, PMID: 28490897 found a similar trend at a lower 250mg/day dose over 12 weeks. A third trial commonly cited alongside these, Handog 2016, PMID: 26148180, is open-label with no control group at all — a real result on its own terms, but the weakest design in the set, and it should never be weighted the same as the two controlled trials.
What matters most for anyone shopping on this claim: every one of those trials used the oral route, not IV. Glutathione marketed for skin lightening is frequently sold or administered as an IV infusion, and that route has neither the efficacy evidence nor the safety record of the oral trials — the Philippine FDA issued a public warning against off-label IV glutathione use after adverse effects (Sonthalia 2016, PMID: 27088927). Oral evidence, however limited, does not transfer to or justify the IV route. Full trial-by-trial detail lives on the absorption & skin-whitening page.
Liver support and oxidative stress: real biochemistry, unproven as a treatment
Glutathione is genuinely the liver's primary detox cofactor and the body's master intracellular antioxidant — that's textbook biochemistry, not a marketing invention. Richie 2015 also found the oxidized-to-reduced glutathione ratio improved in both dose groups, a real biomarker shift. What no trial in this evidence set has done is test oral glutathione against an actual diagnosed liver condition — fatty liver, hepatitis, or otherwise. "Supports liver detox" describes a real mechanism; "treats liver disease" is a claim this evidence doesn't reach. If raising glutathione for liver support is the actual goal, NAC has the stronger, cheaper, drug-grade case: it's the FDA-approved antidote for acetaminophen overdose specifically because it restores liver glutathione. See the full liver & oxidative-stress page and NAC for liver & glutathione for the comparison.
Immune function: one real signal, not a proven benefit
Immune support is a common claim on glutathione labels, and the evidence for it is thinner than for absorption or even skin lightening. The one data point comes from inside Richie 2015 itself: natural-killer-cell cytotoxicity, a marker of innate immune activity, more than doubled in the high-dose (1000mg/day) group compared to placebo at 3 months. That's a genuine finding worth naming — but it was a secondary, exploratory measurement in a single 54-person trial, not a dedicated immune-outcome study, and it hasn't been replicated. A single secondary marker moving in one trial is evidence a mechanism is plausible; it is not evidence that supplementing glutathione measurably changes how often you get sick or how well you recover. Treat "supports immune function" as the weakest of the claims graded on this page, not the strongest.
Oral vs. liposomal vs. S-acetyl vs. NAC: which route actually raises glutathione
Every delivery-form claim in this category should be checked against the same question: has anyone actually measured this form's glutathione levels in a human trial? Judged that way, the field narrows fast.
- Standard reduced glutathione (oral capsule): the only form with a direct, multi-tissue human trial behind it — Richie 2015's dose-dependent result. This is the form to default to if you want the evidence, not the marketing story.
- Liposomal glutathione: claimed to absorb better because the lipid coating protects it in the gut. The only supporting data is a rat pharmacokinetic study (Byeon 2019, PMID: 30843439) that found a modest 5-11% absorption advantage over a commercial capsule — animal data, not a human trial. Treat "liposomal absorbs better" as an unverified claim in humans until someone runs that trial.
- S-acetyl-glutathione: claimed to resist breakdown by gut peptidases via its acetyl group. It has a solid animal toxicology package (Camillerapp 2025, PMID: 39892735, NOAEL 1500mg/kg/day) establishing it's safe, but no published human bioavailability trial verified in this evidence set. Its "more bioavailable" pitch rests on a plausible mechanism, not a head-to-head human comparison.
- Sublingual glutathione: the only form that beat standard oral capsules in an actual human head-to-head — Schmitt 2015 found it raised plasma glutathione significantly more than standard oral capsules over 3 weeks. Ironically the best human evidence for a "better absorbed" claim belongs to sublingual, not liposomal or S-acetyl, and it rarely gets marketed on that basis.
- NAC (N-acetylcysteine), as a precursor: rather than supplying glutathione directly, NAC supplies cysteine, the amino acid that limits how much glutathione your body can make. Schmitt 2015 tested it in the same trial as oral and sublingual glutathione and found it performed comparably to standard oral glutathione at raising oxidative-stress markers. NAC is also the far better-established molecule clinically — it's an FDA-approved drug, not just a supplement ingredient — and it's typically cheaper per effective dose. For most people whose actual goal is "raise my glutathione," NAC is the more defensible starting point. See NAC for liver & glutathione.
Glutathione benefits at a glance
| Claim | Evidence grade | What the evidence actually shows | Where to read more |
|---|---|---|---|
| Raises your own glutathione levels | Solid | Dose-dependent rise across 5 tissue markers over 6 months (Richie 2015) | Absorption & skin-whitening |
| Skin lightening | Real but thin | Small, short (4-12wk) controlled trials show a modest effect; the weakest cited trial has no control group | Absorption & skin-whitening |
| Liver / oxidative-stress support | Mechanism real, treatment unproven | Genuine detox biochemistry; no trial tested it against diagnosed liver disease | Liver & oxidative stress |
| Immune function | Weakest — one signal | NK-cell cytotoxicity rose in one trial's secondary endpoint, not replicated | This page, above |
| IV glutathione for skin lightening | Not supported | No RCT efficacy evidence; Philippine FDA issued a safety warning after adverse effects | Absorption & skin-whitening |
Glutathione Side Effects: Oral Is Mild, Injectable Is Not
Looking for a tested product? See our best glutathione ranked by cost per actual mg, which links this safety detail too →
Oral glutathione: mild, and here's the mechanistic reason why
If you're taking a glutathione capsule, the side-effect profile is genuinely unremarkable. The trials behind this site's dosage guidance — Richie 2015's 6-month RCT at 250-1000mg/day, and the smaller 4-12 week skin-lightening trials at 250-500mg/day — report no serious adverse events. Occasional mild GI complaints (bloating, cramping) show up in anecdotal reports, but no oral trial in this evidence set quantifies a specific rate.
There's a real, unglamorous reason oral glutathione tends to be so well tolerated, and it's tied directly to the same absorption story covered on our absorption & skin-whitening page: a classic pharmacokinetic study found that oral glutathione's systemic availability is negligible at doses up to 3 grams, because intestinal and hepatic enzymes break it down before it reaches circulation intact (Witschi 1992). That doesn't mean oral glutathione does nothing — Richie 2015's later, longer trial found sustained daily dosing over months does measurably raise your body's own glutathione stores. But at any single dose, relatively little of what you swallow is circulating intact, which is a large part of why there's relatively little of it around to cause a reaction.
The real safety story here isn't oral — it's IV and injectable glutathione for skin whitening. Marketing photos for glutathione routinely show drips and syringes, and that route carries meaningfully more risk than anything an oral capsule does, with real regulatory warnings and real documented harm behind it.
IV and injectable glutathione: what regulators have actually said
Two separate national regulators have flagged injectable glutathione, for two related but distinct reasons, and both are worth knowing plainly.
The Philippine FDA issued a public advisory warning specifically against injectable glutathione for skin lightening. Its stated concerns: no published clinical trials support the injectable route's efficacy for skin lightening, injectable glutathione is not approved for that indication (it is approved there only as an adjunct in cisplatin chemotherapy), and reported risks include toxic effects on the liver, kidneys, and nervous system, plus the possibility of Stevens-Johnson syndrome, a rare and serious skin/mucous-membrane reaction. A review of the skin-whitening literature makes the same point about the evidence gap: no RCT has established IV glutathione's efficacy for lightening skin, and off-label IV use has drawn a public safety warning after adverse effects (Sonthalia 2016).
The harm isn't hypothetical. A 2025 narrative review summarizing a placebo-controlled trial of injectable glutathione for skin lightening reported that 32% of participants developed deranged liver function tests and one participant had anaphylaxis, severe enough that some patients had to stop treatment before the trial ended (Alzahrani 2025). Separately, a documented case series describes seven patients who developed acute systemic inflammatory symptoms — high fever, severe low blood pressure, vomiting, and days-long hospitalization — within two hours of receiving IV glutathione infusions that testing later confirmed were contaminated with bacterial endotoxin far above accepted safety limits (Johnstone 2018). Those particular patients were being treated for a different condition, not skin lightening, but the underlying failure mode is the same one regulators keep flagging: injectable glutathione is often compounded from dietary-supplement-grade powder that was never manufactured or tested to injectable sterility standards. The U.S. FDA has separately and directly warned compounding pharmacies against this practice, after real patients receiving compounded glutathione injections suffered adverse reactions tied to endotoxin contamination in the powder used.
None of the oral or topical evidence discussed on our absorption & skin-whitening page should be read as reassurance about the IV route. They are different products with a different, and considerably worse-documented, risk profile.
Inhaled glutathione and asthma: a specific, real caution
Nebulized or inhaled glutathione shows up in some alternative-lung-health protocols, and there's a specific reason to be cautious if you have asthma. A placebo-controlled crossover trial in eight people with mild asthma found that a single nebulized 600mg glutathione dose caused measurable bronchoconstriction — FEV1 (a standard lung-function measurement) fell 19% versus 1% with placebo, and airway resistance rose 61% versus 17% with placebo, both statistically significant differences. Seven of the eight patients developed cough or breathlessness (Marrades 1997). The likely mechanism is sulfite formation in the nebulized solution, and pre-treatment with a bronchodilator blocked the effect — but the practical takeaway is straightforward: inhaled glutathione is not something to self-administer if you have asthma without a doctor involved.
Zinc status and other long-term unknowns
Two honest gaps are worth naming rather than glossing over. First, some clinical sources caution that glutathione and zinc share metabolic pathways and that sustained, high-dose glutathione supplementation could plausibly affect zinc status over time — but no controlled human trial in this evidence set actually measured zinc levels before and after glutathione supplementation, so this stays a plausible, unproven caution rather than a documented effect. If you take glutathione at a meaningful dose for months at a time, mentioning it to a doctor alongside your usual bloodwork is reasonable; treating it as a confirmed side effect is not.
Second, no trial in this evidence set has tested glutathione safety beyond 6 months. Richie 2015, the longest oral trial behind this site's dosing guidance, ran 6 months. That is not the same claim as "long-term use is dangerous" — it is the claim that nobody has actually looked, which matters if you're planning to take it indefinitely. There is also no safety data at all for pregnancy or breastfeeding, at any dose or route, and no established RDA or upper limit against which to judge a "high" dose in the first place.
Glutathione side effects at a glance
| Route / concern | What's documented | Severity | Who it matters most for |
|---|---|---|---|
| Oral capsule (GI upset) | No serious AEs in the trials behind this site's dosing (Richie 2015 and the skin trials); mild GI complaints reported anecdotally, no quantified rate | Mild | General population, especially at higher doses |
| IV / injectable (skin whitening) | Philippine FDA advisory against the practice; 32% deranged liver function + 1 anaphylaxis case in a reviewed trial (Alzahrani 2025); no RCT efficacy evidence (Sonthalia 2016) | Serious | Anyone considering an IV "glutathione drip" for skin lightening |
| IV / injectable (contamination risk) | U.S. FDA warning to compounders; documented endotoxin-poisoning case series requiring hospitalization (Johnstone 2018) | Serious | Anyone receiving compounded (non-pharmaceutical-grade) glutathione injections, for any reason |
| Inhaled / nebulized | Bronchoconstriction and cough/breathlessness in 7 of 8 mild-asthma patients at 600mg (Marrades 1997) | Moderate-to-serious in asthma | Anyone with asthma or reactive airway disease |
| Zinc status (long-term oral) | Plausible but unproven; no controlled trial measured it | Unknown | Long-term, high-dose oral users |
| Pregnancy / breastfeeding | No safety data at any dose or route | Unknown | Pregnant or nursing individuals |
Frequently asked questions
Does oral glutathione actually get absorbed?
Better than its reputation suggests. Richie 2015 (6-month RCT, n=54) found 250-1000mg/day raised body glutathione stores dose-dependently. But Schmitt 2015 found a sublingual form beat standard oral capsules head-to-head — "oral works" and "oral is the best route" are different claims.
Does glutathione actually lighten skin?
Real but small and short evidence. Arjinpathana 2012 (RCT, n=60, 500mg/4wk) found significance at 2 of several sites, with the authors' own hedge about "a small number of subjects." Handog 2016 is open-label, single-arm, no control — the weakest design here.
Is IV glutathione safe or effective for skin lightening?
Not endorsed here. No RCT efficacy evidence, not FDA-approved for this use, and the Philippine FDA issued a public safety warning after adverse effects (Sonthalia 2016).
Is liposomal or S-acetyl glutathione more bioavailable?
Not proven in humans. Liposomal's edge is a rat-only study (Byeon 2019); S-acetyl has animal safety data (Camillerapp 2025) but no human absorption trial.
What are the real benefits of glutathione supplements?
Graded honestly, there's one solid finding and several thinner ones. Solid: oral glutathione reliably raises your own glutathione levels — Richie 2015, a 6-month RCT in 54 healthy adults, found 250mg and 1000mg/day raised glutathione in blood, plasma, and other tissues in a dose-dependent way. Thinner: skin lightening has real but small, short-term evidence from a couple of controlled trials. Weakest: liver and immune claims rest on plausible biochemistry and, at most, one trial's secondary marker — not on any trial that tested glutathione against a diagnosed disease.
Does oral glutathione actually get absorbed, or is it destroyed in the gut?
The 'destroyed in the gut' claim is overstated at the level of raising your body's own glutathione stores. Richie 2015 (PMID 24791752) measured it directly over 6 months and found real, dose-dependent increases. But a head-to-head trial (Schmitt 2015, PMID 26262996) found a sublingual glutathione formulation raised plasma glutathione significantly more than standard oral capsules — so oral absorption is real, it just may not be the most efficient route tested.
Does glutathione lighten skin, and is that the best-supported use?
It's the most commonly searched-for benefit, but not the best-evidenced one. Two placebo-controlled trials (Arjinpathana 2012, PMID 20524875; Weschawalit 2017, PMID 28490897) found a genuine but small effect over 4-12 weeks at 250-500mg/day. A third trial often cited alongside them (Handog 2016, PMID 26148180) has no control group at all. None of this evidence applies to IV glutathione, which this site does not recommend for skin lightening.
Is glutathione good for the liver, or does it boost immunity?
Both claims lean on real biochemistry that hasn't been tested as a treatment claim. Glutathione is the liver's central detox cofactor, but no trial in this evidence set tested oral glutathione against a diagnosed liver condition. For immunity, Richie 2015 found natural-killer-cell cytotoxicity, an immune marker, more than doubled in the high-dose group at 3 months — a real signal, but a single secondary finding from one trial, not a replicated immune-outcome study.
Should I take glutathione, NAC, or a liposomal/S-acetyl form?
For most people, NAC is the better-evidenced and cheaper route to raising glutathione — it's the FDA-approved acetaminophen-overdose antidote precisely because it restores liver glutathione, and Schmitt 2015 found it performed comparably to oral glutathione at raising plasma levels in the same trial. Liposomal glutathione's absorption edge is a rat study only (Byeon 2019, PMID 30843439). S-acetyl-glutathione has solid animal safety data (Camillerapp 2025, PMID 39892735) but no published human absorption trial. Standard reduced glutathione, the form Richie 2015 actually tested, remains the only oral form with direct human evidence behind it.
What are the most common oral glutathione side effects?
Mild ones, and rarely reported at all. The trials in this evidence set — Richie 2015's 6-month body-stores RCT and the smaller skin-lightening trials — describe no serious adverse events at oral doses of 250-1000mg/day. Occasional mild GI complaints (bloating, cramping) show up anecdotally, but no controlled oral trial in this pack reports a specific rate. Part of the reason oral glutathione is so mild is the same reason it was long thought not to work at all: most of a swallowed dose is broken down by gut and liver enzymes before it reaches your bloodstream intact (Witschi 1992), so there's relatively little of it circulating to cause a reaction.
Is IV or injectable glutathione safe?
This is the real safety question in this category, and the answer is no — not established as safe, and not approved for skin lightening. The Philippine FDA issued a public advisory warning against injectable glutathione for skin lightening specifically, citing liver, kidney, and nervous-system toxicity risk and the possibility of Stevens-Johnson syndrome, and noting no clinical trials support its efficacy for that use. In the U.S., the FDA has separately warned compounding pharmacies against making sterile glutathione injections from dietary-supplement-grade powder, after real patients suffered adverse reactions traced to bacterial endotoxin contamination. A 2025 narrative review (Alzahrani 2025) summarizing an injectable skin-lightening trial found severe deranged liver function tests in 32% of participants and one case of anaphylaxis, serious enough that some patients had to stop treatment.
Can glutathione supplementation lower zinc levels?
Possibly, but it isn't established. Some clinical sources caution that glutathione and zinc are metabolically linked and that long-term, high-dose glutathione supplementation could affect zinc status — but no controlled human trial in this evidence set actually measured zinc levels before and after glutathione supplementation. Treat this as a plausible, unproven caution worth mentioning to a doctor if you take glutathione long-term, not a documented side effect.
Is inhaled or nebulized glutathione safe for people with asthma?
No — this is a specific, well-documented caution. A placebo-controlled crossover trial in people with mild asthma (Marrades 1997) found that a single nebulized 600mg glutathione dose dropped lung function sharply (FEV1 fell 19%, versus 1% with placebo) and caused cough or breathlessness in 7 of 8 patients, an effect the researchers attributed to sulfite formation and that pre-treatment with a bronchodilator blocked. Inhaled glutathione is not something to try if you have asthma without a doctor's guidance.
Is long-term glutathione supplementation safety established?
No. The longest controlled oral trial in this evidence set ran 6 months (Richie 2015); nothing has tested years of continuous use. There's no established RDA or upper limit, and no safety data at all for pregnancy or breastfeeding at any dose or route. None of that means long-term oral use is dangerous — it means it hasn't been studied, which is a different, more honest claim.
Related guides
- NAC for Liver & Glutathione — the cheaper, better-evidenced route to raising glutathione
- Vitamin C — another antioxidant nutrient with its own absorption-ceiling story
- NMN — another longevity-marketed ingredient where a rigorous result gets skipped past in marketing
- CoQ10 — another mitochondrial-antioxidant supplement with its own bioavailability-form debate
Sources
- Richie JP, et al. "Randomized controlled trial of oral glutathione supplementation on body stores of glutathione." Eur J Nutr. 2015. PMID: 24791752
- Weschawalit S, et al. "Glutathione and its antiaging and antimelanogenic effects." Clin Cosmet Investig Dermatol. 2017. PMID: 28490897
- Arjinpathana N, Asawanonda P. "Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study." J Dermatolog Treat. 2012. PMID: 20524875
- Handog EB, et al. "An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent." Int J Dermatol. 2016. PMID: 26148180
- Schmitt B, et al. "Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual GSH formulation on plasma markers." Redox Biol. 2015. PMID: 26262996
- Byeon JS, et al. "Comparative pharmacokinetics of glutathione proliposome formulations in rats." Drug Deliv. 2019. PMID: 30843439 (rat study, not human).
- Camillerapp C, et al. "Toxicological evaluation of S-acetyl-glutathione." Food Chem Toxicol. 2025. PMID: 39892735 (animal safety, not human bioavailability).
- Sonthalia S, et al. "Glutathione as a skin whitening agent: Facts, myths, evidence and controversies." Indian J Dermatol Venereol Leprol. 2016. PMID: 27088927
- Full product dataset: /glutathione/cost-by-brand.json (CC BY 4.0).
- Witschi A, et al. "The systemic availability of oral glutathione." Eur J Clin Pharmacol. 1992;43(6):667-9. PMID: 1362956
- Marrades RM, et al. "Nebulized glutathione induces bronchoconstriction in patients with mild asthma." Am J Respir Crit Care Med. 1997;156(2 Pt 1):425-30. PMID: 9279219
- Alzahrani TF, et al. "Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review." Cureus. 2025;17(1):e78045. PMID: 40013212
- Johnstone J, et al. "Seven cases of probable endotoxin poisoning related to contaminated glutathione infusions." Epidemiol Infect. 2018;146(7):931-934. PMID: 29673413
- Philippine Food and Drug Administration. FDA Advisory No. 2019-182, "Unsafe Use of Glutathione as Skin Lightening Agent." (Regulatory advisory, no PMID.)
- U.S. Food and Drug Administration. "FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables." Human Drug Compounding safety communication. (Regulatory advisory, no PMID.)